UPDATE - UBS Downgrades Alkermes (ALKS) to Neutral; Bydureon’s Delay Puts Overhang on Shares
Tweet Send to a Friend
UPDATE - UBS downgrades Alkermes (Nasdaq: ALKS) from Buy to Neutral. PT slashed from $18 to $11.
UBS analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
